We want our patients involved in shared decision-making. But do patients feel they are? A report by Alokozai et al. in the May 4, 2022
May 3, 2022 – Tranexamic acid (TXA) – a medication given to reduce the risk of bleeding during some orthopaedic surgical procedures – can be
In a recent report in JBJS, Holler et al. investigated risk factors for delayed management of open tibial fractures in Tanzania. As the authors note,
Co-author Rachel M. Frank, MD summarizes the 5 most compelling findings from among the studies highlighted in the new “What’s New in Sports Medicine” in JBJS.
A periacetabular osteotomy (PAO) is a surgical treatment for hip dysplasia that has been shown in adult patients to delay the onset of hip arthritis
Surgical site infections (SSIs) can be devastating complications for orthopaedic patients. A new study published in Nature advances our understanding of drug-resistant pathogens that can
April 13, 2022 – Patients with lower levels of sex hormones – testosterone in men and estrogen in women – are more likely to undergo
One of the great things about the OrthoJOE podcast is the unexpected places a conversation can go, leaving the listener richer for tuning in. In the
This guest post comes from Jaime Bellamy, DO in response to a recent randomized clinical trial reported in JAMA Network Open and featured in MedPage
A randomized clinical trial remains at the top of the Level of Evidence pyramid precisely because this experimental design is the optimum way to limit